# Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

> **NCT06995482** · PHASE1 · RECRUITING · sponsor: **Kashiv BioSciences, LLC** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Postmenopausal Women

## Interventions

- **DRUG:** KSHN001034
- **DRUG:** KSHN001034
- **DRUG:** KSHN001034
- **DRUG:** KSHN001034
- **DRUG:** KSHN001034
- **DRUG:** Fulvestrant

## Key facts

- **NCT ID:** NCT06995482
- **Lead sponsor:** Kashiv BioSciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-18
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995482, "Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06995482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*